Avis Tablet
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
MFDS item code 201501744 · Approved 2015.03.31
This product's status changed to Expired on 2025.03.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers and gastritis); prevention of Mendelson syndrome
This medication is used for gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, gastroesophageal reflux disease, and other gastrointestinal disorders. It is also effective for pre-operative administration to prevent Mendelson's syndrome and for postoperative ulcer treatment. It is indicated for the treatment of gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). This drug alleviates symptoms of various diseases caused by excess stomach acid and promotes tissue recovery. It is a medication that helps improve gastric health for patients.
Usually, take 2 tablets per dose orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily or 4 tablets per dose once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and for combination therapy to prevent gastric and duodenal ulcers during long-term NSAID use. Diseases caused by NSAID administration are usually cured within 4 weeks, and ulcers are usually cured within 8 weeks, although the healing period may sometimes be longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks or 4 tablets per dose once daily at bedtime. However, the dose may be increased to 4 tablets per dose 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets per dose 3 times daily, and increase the dose as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets per dose on the night before surgery.
This medication should not be used in patients with impaired kidney function or those undergoing dialysis. Furthermore, patients with a history of allergic reactions to this drug or any of its components should avoid its use. Patients with a rare disease known as acute porphyria may experience worsening symptoms and should not use this drug. In addition, patients who have undergone upper gastrointestinal tract surgery, pregnant women or those who may become pregnant, premature infants, and newborns, as well as patients who need to limit their potassium intake, should also avoid using this drug. Patients with compromised liver function, those with a history of drug allergies, elderly patients, and individuals with a history of kidney dysfunction should use this medication with caution. When taken with NSAIDs, special precautions are needed, and regular testing may be required. This medication can mask symptoms of gastric cancer, so it should only be administered to patients with gastric ulcers or those showing recent indigestion symptoms after ensuring that they do not have malignant diseases. Patients with Helicobacter pylori infection and gastric/duodenal ulcers may require bacterial eradication therapy. Caution should be exercised when used in critically ill patients in the intensive care unit, those with hypophosphatemia, and patients with swallowing difficulties. During use, rare allergic reactions, blood abnormalities, liver function abnormalities, cardiac arrhythmias, gastrointestinal symptoms, neuropsychiatric symptoms, muscle pain, and skin rashes may occur, so if any unusual symptoms arise, patients should consult a physician immediately. Long-term use is not recommended, and if there is no therapeutic effect, a change to another medication may be necessary. If dizziness or drowsiness occurs, patients should avoid driving or operating dangerous machinery. This medication may interact with other drugs, so it is important to inform healthcare providers of any other medications being taken, especially when taken in conjunction with anticoagulants, antibiotics, or analgesics. It is safest for pregnant or breastfeeding women to avoid this medication. Safety for pediatric use has not been established and it is not recommended for children. In case of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and blood dialysis may be helpful in some cases. Lastly, this medication may reduce stomach acid secretion, potentially promoting bacterial growth in the gastrointestinal tract, so ocular examinations may be required in long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from exposure to air, and it is best to keep it at a temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness and prevent degradation.
Green round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.